Table 2.
Clinical characteristics and underlying diseases of patients
| Patient’s characteristics | Number (%) or mean±SD | |
|---|---|---|
| Gender | ||
| Female | 8 (31) | |
| Male | 20 (69) | |
| Age | 59.21±19.42 | |
| WBC and vital sign: | Before treatment | After treatment |
| WBC(× 103 per μL) | 14.34±5.42 | 9.49±3.72 |
| HR(beats per minute) | 103.37±20.04 | 96.27±19.9 |
| RR (breaths per minute) | 22.21±7.06 | 15.39±3.52 |
| MAP (mmHg) | 88.92±16.55 | 87.09±11.38 |
| T (°C) | 37.87±1.15 | 37.11±0.52 |
| Charlson comorbidity score | 3.83±2.71 | |
| DM | 7 (24.13%) | |
| CHF | 1(3.45%) | |
| IHD | 4 (13.79%) | |
| HTN | 8 (27.59%) | |
| COPD | 7 (24.13%) | |
| CKD | 1(3.45%) | |
| CVA | 2 (6.9%) | |
| Parkinson | 3(10.34%) | |
| Alzheimer disease | 1(3.45%) | |
| Solid tumor | ||
| Non-metastatic | 5 (17.24%) | |
| Metastatic | 2 (6.9%) | |
| Thyroid disorder | 1 (3.45%) | |
| CIDP | 1 (3.45%) |
DM, diabetes mellitus; CHF, chronic heart failure; IHD, ischemic heart disease; HTN, hypertension; COPD, chronic obstructive pulmonary disease; CKD, chronic kidney disease; CVA, cerebrovascular accident; CIDP, chronic inflammatory demyeliniating polyneuropathy; WBC, white blood cell; HR, heart rate; RR, respiratory rate; MAP, mean arterial pressure; T, temperature.